[1] Sari F, Sari R, Ozdem S, et al.Serum prolactin and macroprolactin levels in diabetic nephropathy[J]. Clin Nephrol, 2012, 78(1):33-39. [2] 崔燕, 王慧敏, 魏玮. 老年慢性肾脏病的常见病因及首发症状分析[J]. 中国全科医学, 2012,15(11):1244-1245. [3] Ziyadeh FN, Wolf G.Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy[J]. Curr Diabetes Rev, 2008, 4(1):39-45. [4] Son SM.Reactive oxygen and nitrogen species in pathogenesis of vascular complications of diabetes[J]. Diabetes Metab J, 2012, 36(3):190-198. [5] 沈水娟, 胡作祥, 王时敏, 等. 黄葵胶囊联合雷公藤多苷片治疗Ⅳ期糖尿病肾病的疗效观察[J]. 中国临床药理学与治疗学, 2011, 16(1):85-88. [6] 李新, 陈向东, 李忠心. 大剂量厄贝沙坦治疗慢性肾脏病患者临床蛋白尿的疗效及安全性[J]. 中华内科杂志, 2011, 50(12):1034-1038. [7] Persson F, Rossing P, Hovind P, et al.Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy[J]. Diabetes, 2006, 55(12):3550-3555. [8] Siu JT, Tejani AM, Musini V, et al.Hypertension control in patients with diabetes[J]. Can Fam Physician, 2012, 58(1):31-33. [9] Onozato ML, Tojo A, Goto A, et al.Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB[J]. Kidney Int, 2002, 61(1):186-194. [10] Son SM.Role of vascular reactive oxygen species in development of vascular abnormalities in diabetes[J]. Diabetes Res Clin Pract, 2007, 77(Suppl 1):S65-70. [11] Harris RC.Podocyte ACE2 protects against diabetic nephropathy[J]. Kidney Int, 2012, 82(3):255-256. [12] Campbell KN, Raij L, Mundel P.Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes[J]. Curr Diabetes Rev, 2011, 7(1):3-7. [13] Broedbaek K, Henriksen T, Weimann A, et al.Long-term effects of Irbesartan treatment and smoking on nucleic acid oxidation in patients with type 2 diabetes and microalbuminuria: an Irbesartan in patients with type 2 diabetes and Microalbuminuria (IRMA 2) substudy[J]. Diabetes Care, 2011, 34(5):1192-1198. [14] D'Elia JA, Bayliss G, Roshan B, et al. Diabetic microvascular complications: possible targets for improved macrovascular outcomes[J]. Int J Nephrol Renovasc Dis, 2011, 4:1-15. |